TY - JOUR
T1 - Accelerometer data collected with a minimum set of wearable sensors from subjects with Parkinson’s disease
AU - Daneault, Jean Francois
AU - Vergara-Diaz, Gloria
AU - Parisi, Federico
AU - Admati, Chen
AU - Alfonso, Christina
AU - Bertoli, Matilde
AU - Bonizzoni, Edoardo
AU - Carvalho, Gabriela Ferreira
AU - Costante, Gianluca
AU - Fabara, Eric Eduardo
AU - Fixler, Naama
AU - Golabchi, Fatemah Noushin
AU - Growdon, John
AU - Sapienza, Stefano
AU - Snyder, Phil
AU - Shpigelman, Shahar
AU - Sudarsky, Lewis
AU - Daeschler, Margaret
AU - Bataille, Lauren
AU - Sieberts, Solveig K.
AU - Omberg, Larsson
AU - Moore, Steven
AU - Bonato, Paolo
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Parkinson’s disease (PD) is a neurodegenerative disorder associated with motor and non-motor symptoms. Current treatments primarily focus on managing motor symptom severity such as tremor, bradykinesia, and rigidity. However, as the disease progresses, treatment side-effects can emerge such as on/off periods and dyskinesia. The objective of the Levodopa Response Study was to identify whether wearable sensor data can be used to objectively quantify symptom severity in individuals with PD exhibiting motor fluctuations. Thirty-one subjects with PD were recruited from 2 sites to participate in a 4-day study. Data was collected using 2 wrist-worn accelerometers and a waist-worn smartphone. During Days 1 and 4, a portion of the data was collected in the laboratory while subjects performed a battery of motor tasks as clinicians rated symptom severity. The remaining of the recordings were performed in the home and community settings. To our knowledge, this is the first dataset collected using wearable accelerometers with specific focus on individuals with PD experiencing motor fluctuations that is made available via an open data repository.
AB - Parkinson’s disease (PD) is a neurodegenerative disorder associated with motor and non-motor symptoms. Current treatments primarily focus on managing motor symptom severity such as tremor, bradykinesia, and rigidity. However, as the disease progresses, treatment side-effects can emerge such as on/off periods and dyskinesia. The objective of the Levodopa Response Study was to identify whether wearable sensor data can be used to objectively quantify symptom severity in individuals with PD exhibiting motor fluctuations. Thirty-one subjects with PD were recruited from 2 sites to participate in a 4-day study. Data was collected using 2 wrist-worn accelerometers and a waist-worn smartphone. During Days 1 and 4, a portion of the data was collected in the laboratory while subjects performed a battery of motor tasks as clinicians rated symptom severity. The remaining of the recordings were performed in the home and community settings. To our knowledge, this is the first dataset collected using wearable accelerometers with specific focus on individuals with PD experiencing motor fluctuations that is made available via an open data repository.
UR - http://www.scopus.com/inward/record.url?scp=85100560821&partnerID=8YFLogxK
U2 - 10.1038/s41597-021-00830-0
DO - 10.1038/s41597-021-00830-0
M3 - Article
C2 - 33547309
AN - SCOPUS:85100560821
SN - 2052-4463
VL - 8
JO - Scientific data
JF - Scientific data
IS - 1
M1 - 48
ER -